CRT 2025
Coronary
Cardiogenic Shock
Mitchell Krucoff, MD, FACC, FAHA, FSCAI
Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing); Cook medical: Consultant (Ongoing); Getinge: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Consultant (Ongoing); Johnson & Johnson: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); OrbusNeich Medical Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Srihari S. Naidu, MD, FSCAI
Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States
Disclosure(s): No financial relationships to disclose
Vinoy S. Prasad, MD, FACC, FSCAI
Director of Interventional Cardiology
Loma Linda University Medical Center
Redlands, California, United States
Disclosure(s): No financial relationships to disclose